Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.76
Delayed Data
As of 1:36pm ET
 -0.02 / -1.12%
Today’s Change
0.84
Today|||52-Week Range
5.79
+30.37%
Year-to-Date
Catalyst Pharmaceuticals (CPRX) Posts Loss as Expected in Q1
May 11 / Zacks.com - Paid Partner Content
Infinity (INFI) Reports Narrower-than-Expected Loss in Q1
May 10 / Zacks.com - Paid Partner Content
Endocyte (ECYT) Reports Narrower-than-Expected Loss in Q1
May 11 / Zacks.com - Paid Partner Content
Endo (ENDP) Beats on Q1 Earnings, Reaffirms '17 Guidance
May 09 / Zacks.com - Paid Partner Content
Valeant (VRX) Q1 Earnings & Revenues Miss, View Raised
May 10 / Zacks.com - Paid Partner Content
Horizon (HZNP) Falls on Q1 Earnings Miss, Guidance Trimmed
May 09 / Zacks.com - Paid Partner Content
Prothena (PRTA) Q1 Loss Narrower than Expected, Updates View
May 10 / Zacks.com - Paid Partner Content
Catalent (CTLT) Shows Strength: Stock Adds 9.8% in Session
May 08 / Zacks.com - Paid Partner Content